GRAND MING (01271) intends to sell all the equities of Yuet Kee Development and Golden Wealth.
Jia Ming Group Holdings (01271) announced that on June 19, 2025, its wholly-owned subsidiary Wel...
GRAND MING (01271) announced that on June 19, 2025, its wholly-owned subsidiary, Wellford Properties Holdings Limited (Wellford Properties), received an indicative letter of intent signed by a potential buyer on June 16, 2025, to discuss the potential acquisition of Joybase Development Limited (Joybase Development) and Golden Rich Limited (Golden Rich, together with Joybase Development, collectively referred to as the "target companies") (both companies are direct wholly-owned subsidiaries of Wellford Properties and also indirect wholly-owned subsidiaries of the company).
The target companies are limited companies registered in Hong Kong, mainly engaged in property development. As of the date of this announcement, they are both direct wholly-owned subsidiaries of Wellford Properties and indirect wholly-owned subsidiaries of the company.
After considering the Group's current financial position and strategic goals, the board of directors believes that if the potential transaction is realized, the net proceeds will help the Group reduce its overall debt and thereby improve the Group's financial position.
Related Articles

HK Stock Market Move | ORIENTAL WATCH (00398) fell more than 5% after the performance report. Annual net profit attributable to shareholders decreased by 19.96% year-on-year.

Bill Gates' nuclear energy startup company TerraPower raised $650 million in funding, with investment from NVIDIA Corporation's venture capital department.

Bank of America Securities: Raised SINO BIOPHARM (01177) target to HK$5.9, reiterating "buy" rating.
HK Stock Market Move | ORIENTAL WATCH (00398) fell more than 5% after the performance report. Annual net profit attributable to shareholders decreased by 19.96% year-on-year.

Bill Gates' nuclear energy startup company TerraPower raised $650 million in funding, with investment from NVIDIA Corporation's venture capital department.

Bank of America Securities: Raised SINO BIOPHARM (01177) target to HK$5.9, reiterating "buy" rating.

RECOMMEND

The “Toughest Battery Safety Regulation in History” to Be Implemented, Shifting Focus from “Energy Density” to “Safety”
19/06/2025

Nippon Steel Completes Global Expansion Following Full Acquisition of U.S. Steel
19/06/2025

The Federal Reserve Holds Rates Steady, Notes Easing Uncertainty Yet Elevated Risks, Maintains Projection of Two Cuts in 2024, Signals Stagflation Risks May Be Rising
19/06/2025